TARA CONLEY: Open Payments
NPI 1659662799 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,976 in 164 payments from 20 companies in 2025. Trend: 2023 $2,308 · 2024 $2,556 · 2025 $3,976
Food & beverage: $2,731Consulting: $1,245
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $1,698 |
| ABBVIE INC. | 27 | $467 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 29 | $380 |
| Celltrion USA Inc. | 22 | $319 |
| GENZYME CORPORATION | 6 | $195 |
| PFIZER INC. | 16 | $193 |
| Aimmune Therapeutics, Inc. | 17 | $154 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| Ipsen Biopharmaceuticals, Inc | 3 | $64 |
| Lilly USA, LLC | 3 | $63 |
Products named: TREMFYA, XIFAXAN, VEGZELMA, MAVYRET, DUPIXENT, VELSIPITY, CREON, ZENPEP.
Industry payments across TX — which companies pay providers there.
